Skip to Content
Merck
CN
  • Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin.

Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin.

Aging (2015-11-06)
Fei Yue, Wenjiao Li, Jing Zou, Qi Chen, Guibin Xu, Hai Huang, Zhen Xu, Sheng Zhang, Paola Gallinari, Fen Wang, Wallace L McKeehan, Leyuan Liu
ABSTRACT

Autophagy controls and executes the turnover of abnormally aggregated proteins. MAP1S interacts with the autophagy marker LC3 and positively regulates autophagy flux. HDAC4 associates with the aggregation-prone mutant huntingtin protein (mHTT) that causes Huntington's disease, and colocalizes with it in cytosolic inclusions. It was suggested HDAC4 interacts with MAP1S in a yeast two-hybrid screening. Here, we found that MAP1S interacts with HDAC4 via a HDAC4-binding domain (HBD). HDAC4 destabilizes MAP1S, suppresses autophagy flux and promotes the accumulation of mHTT aggregates. This occurs by an increase in the deacetylation of the acetylated MAP1S. Either suppression of HDAC4 with siRNA or overexpression of the MAP1S HBD leads to stabilization of MAP1S, activation of autophagy flux and clearance of mHTT aggregates. Therefore, specific interruption of the HDAC4-MAP1S interaction with short peptides or small molecules to enhance autophagy flux may relieve the toxicity of mHTT associated with Huntington's disease and improve symptoms of HD patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nα-Acetyl-L-lysine
Sigma-Aldrich
Anti-acetyl-Lysine Antibody, clone 4G12, clone 4G12, Upstate®, from mouse
Sigma-Aldrich
Anti-acetyl Lysine Antibody, clone 4G12, agarose conjugate, clone 4G12, Upstate®, from mouse